European Manufacturing Giant Selects Labvantage
News Apr 25, 2012
LABVANTAGE has announced that an European manufacturing giant has selected its LIMS solution to replace its existing LIMS to meet GLP-requirements at its R&D headquarters. The solution will manage next generation product testing, part of the research and development pipeline, for key functionality such as stability testing, chemistry, and physicochemical testing. LABVANTAGE provides a user-friendly, intuitive and configurable GUI, delivered entirely via thin-client web browser. The new LIMS will also manage the facility’s extensive library of study protocols while enabling better decision making through its advanced reporting and analytics. LABVANTAGE’s Advanced Storage and Logistics, CAPA (Corrective Actions, Preventive Actions) and Connect Advanced Instrument Interface will also be deployed.
“This project provides an out-of-the-box LIMS solution that fully fits into the customer’s existing product life-cycle management process and further validates our investment into this part of the customer enterprise. We remain confident that our substantial investments into our own product portfolio will continue to extend our competitive differentiation in this legacy replacement market,” says Jeff Ferguson, LABVANTAGE Chief Executive Officer.
The implementation will be deployed in three phases: analysis request, logistics, and chemistry assessment-related analyses in phase one; product development support, batch release support and stability for phase two; and in vitro testing for phase three.
Bioinformatics to Help Understand Intrinsically Disordered ProteinsNews
Over the last several decades, scientists have sequenced 85 million unique proteins, structured and unstructured alike, but still don’t know what the vast majority of these proteins do.READ MORE
Understanding the Cellular Systems that Hold Back the Spread of CancerNews
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.READ MORE